Showing results (91-100 of 122) with videos related to

Sort By:
Pageof 13
Theranostics|November 1, 2023
Engineered oncolytic bacteria HCS1 exerts high immune stimulation and safety profiles for cancer therapyYujie Sun, Yanxia Guo, Xiaoqing Liu, et al.
Oncology Reports|October 4, 2019
Downregulation of MUTYH contributes to cisplatin‑resistance of esophageal squamous cell carcinoma cells by promoting Twist‑mediated EMTYanxia Guo, Yuxiu Jia, Shikang Wang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 17, 2021
Targeting of pancreatic cancer cells and stromal cells using engineered oncolytic Salmonella typhimuriumWenzhi Tan, Mai Thi-Quynh Duong, Chaohui Zuo, et al.
Journal of Medicinal Chemistry|April 10, 2015
ent-Kaurane Diterpenoids from Chinese Liverworts and Their Antitumor Activities through Michael Addition As Detected in Situ by a Fluorescence ProbeZhaomin Lin, Yanxia Guo, Yanhui Gao, et al.
Scientific Reports|December 9, 2022
Effects of small molecule-induced dimerization on the programmed death ligand 1 protein life cycleIlean Chai, Dmytro Kornyeyev, Edward Hsieh, et al.
The Journal of Clinical Investigation|February 9, 2016
T regulatory cell chemokine production mediates pathogenic T cell attraction and suppressionScott J Patterson, Anne M Pesenacker, Adele Y Wang, et al.
Diabetes|January 21, 2016
A Regulatory T-Cell Gene Signature Is a Specific and Sensitive Biomarker to Identify Children With New-Onset Type 1 DiabetesAnne M Pesenacker, Adele Y Wang, Amrit Singh, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 2010
Leishmania exosomes modulate innate and adaptive immune responses through effects on monocytes and dendritic cellsJudith Maxwell Silverman, Joachim Clos, Eva Horakova, et al.
Cytotherapy|September 20, 2011
Cellular magnetic resonance imaging of monocyte-derived dendritic cell migration from healthy donors and cancer patients as assessed in a scid mouse modelXizhong Zhang, Sonali N de Chickera, Christy Willert, et al.
The Journal of Clinical Investigation|May 5, 2011
Autoimmune melanocyte destruction is required for robust CD8+ memory T cell responses to mouse melanomaKatelyn T Byrne, Anik L Côté, Peisheng Zhang, et al.
Pageof 13